Alliant Energy (LNT) Forms $42.50 Double Top; Natus Medical (BABY) Had 3 Bullish Analysts

Alliant Energy Corporation (LNT) formed double top with $43.78 target or 3.00% above today’s $42.50 share price. Alliant Energy Corporation (LNT) has $9.83B valuation. The stock increased 0.43% or $0.18 during the last trading session, reaching $42.5. About 1.08M shares traded. Alliant Energy Corporation (NYSE:LNT) has risen 11.22% since December 25, 2016 and is uptrending. It has underperformed by 5.48% the S&P500.

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 9 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Mkt Perform” rating on Thursday, February 2 by Raymond James. The rating was maintained by Roth Capital with “Buy” on Friday, June 23. The firm has “Outperform” rating given on Tuesday, September 13 by Raymond James. The firm has “Buy” rating given on Thursday, July 23 by TH Capital. The firm earned “Buy” rating on Tuesday, April 5 by Roth Capital. The stock of Natus Medical Incorporated (NASDAQ:BABY) earned “Buy” rating by TH Capital on Tuesday, January 12. The stock has “Buy” rating by Roth Capital on Monday, September 11. TH Capital maintained the stock with “Buy” rating in Thursday, October 22 report. Benchmark initiated the shares of BABY in report on Tuesday, October 4 with “Buy” rating. See Natus Medical Incorporated (NASDAQ:BABY) latest ratings:

11/09/2017 Broker: Roth Capital Rating: Buy New Target: $44.0 Maintain

Investors sentiment decreased to 0.76 in 2017 Q3. Its down 0.41, from 1.17 in 2017Q2. It turned negative, as 32 investors sold Natus Medical Incorporated shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Natus Medical Incorporated (NASDAQ:BABY). Ameritas Partners holds 0% or 2,809 shares. Mason Street Advsrs Ltd Com owns 8,396 shares or 0.01% of their US portfolio. Moreover, Jpmorgan Chase & has 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 37,767 shares. Tiaa Cref Invest Management Limited Com has 0% invested in Natus Medical Incorporated (NASDAQ:BABY). Legal & General Grp Public Ltd Com owns 63,682 shares or 0% of their US portfolio. Rhumbline Advisers reported 0.01% stake. Guggenheim Cap Ltd Liability Corporation accumulated 0% or 9,736 shares. Bank Of Montreal Can has invested 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY). Peak6 Investments Ltd Partnership reported 48,155 shares stake. Us Savings Bank De invested in 2,653 shares. Martingale Asset Mngmt L P owns 13,502 shares or 0.01% of their US portfolio. Citadel Advisors Ltd Liability reported 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY). Moreover, Cap Management has 0.02% invested in Natus Medical Incorporated (NASDAQ:BABY). Envestnet Asset invested 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY).

The stock decreased 0.77% or $0.3 during the last trading session, reaching $38.55. About 122,117 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since December 25, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Since August 14, 2017, it had 0 insider purchases, and 2 insider sales for $257,048 activity. GUNST ROBERT A sold $154,748 worth of stock. $102,300 worth of stock was sold by MOORE WILLIAM M on Monday, August 14.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $1.18 billion. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The companyÂ’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

Since September 7, 2017, it had 0 insider buys, and 1 insider sale for $85,665 activity. On Thursday, September 7 the insider RESCHKE WAYNE A sold $85,665.

Analysts await Alliant Energy Corporation (NYSE:LNT) to report earnings on February, 22. They expect $0.39 earnings per share, up 39.29% or $0.11 from last year’s $0.28 per share. LNT’s profit will be $90.17 million for 27.24 P/E if the $0.39 EPS becomes a reality. After $0.75 actual earnings per share reported by Alliant Energy Corporation for the previous quarter, Wall Street now forecasts -48.00% negative EPS growth.